 |
 | Services
| |
 |
Aliases & Descriptions for SLC2A1
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc
, and/or 7Ensembl,
8miRBase) About This Section
|
| Aliases |
|---|
| DYT17 2 | | DYT18 1, 2, 5 | | GLUT 2 | | GLUT-1 3 | | GLUT1 2, 3, 5 | | MGC141895 2 | | MGC141896 2 | | OTTHUMP00000009006 2 | | PED 2, 5 |
| | | Descriptions |
|---|
| Glucose transporter type 1, erythrocyte/brain 3 | | HepG2 glucose transporter 3 | solute carrier family 2 (facilitated glucose transporter), member 1 2 |
|
| | Search outside databases for aliases for SLC2A1 genePrevious GC identifers: GC01P043382 GC01M042395 GC01M042855 GC01M042804 GC01M043060 |
Summaries for SLC2A1(According to Entrez Gene,
Wikipedia's
Gene Wiki,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| EntrezGene summary for SLC2A1: This gene encodes a major glucose transporter in the mammalian blood-brain barrier. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq] UniProtKB/Swiss-Prot: GTR1_HUMAN, P11166Function: Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexosesGene Wiki entry for SLC2A1 (GLUT1) |
Genomic Location for SLC2A1
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 36),
and/or miRBase,
Genomic Views according to
UCSC and
Ensembl,
Transcription factor binding sites according to
SABiosciences) About This Section
| Genomic View: UCSC Golden Path with GeneCards custom track
Transcription factor binding sites upstream to the SLC2A1 gene 
Entrez Gene cytogenetic band: 1p35-p31.3 Ensembl cytogenetic band: 1p34.2 HGNC cytogenetic band: 1p34.2SLC2A1 Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)
 GeneLoc gene densities for chromosome 1 GeneLoc Exon Structure GeneLoc location for GC01M043164:
(about GC identifiers)
Start:
|
43,164,102 bp from pter |
End:
|
43,197,126 bp from pter |
Size:
|
33,025 bases |
Orientation:
|
minus strand |
RefSeq DNA sequence:- NC_000001.9 NT_032977.8
| Proteins for SLC2A1
(According to
1UniProtKB,
and/or Ensembl,
Phosphorylation sites according to 2Phosphosite,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Enzo Life Sciences,
Abnova,
OriGene and/or,
Abcam,
Biochemical Assays by
Invitrogen,
Millipore,
R&D Systems,
Cell Signaling Technology, and/or
Enzo Life Sciences,
Ontologies according to Gene
Ontology Consortium 01 Apr 2009 and
Entrez Gene,
Antibodies by Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Cell Signaling Technology,
Abcam,
Abnova, and/or
Novus Biologicals)
About This Section
| UniProtKB/Swiss-Prot: GTR1_HUMAN, P11166 (See
protein sequence)Recommended Name: Solute carrier family 2, facilitated glucose transporter member 1 Size: 492 amino acids; 54084 Da
Subcellular location: Cell membrane; Multi-pass membrane protein (By similarity). Melanosome. Note=Localizes primarily at the cell surface (By similarity). Identified by mass spectrometry in melanosome fractions from stage I to stage IV
PDB structures from and Proteopedia :1SUK (3D)
 
Secondary accessions: B2R620 O75535 Q147X2Post-translational modifications:
Phosphorylated upon DNA damage, probably by ATM or ATR1
View phosphorylation sites using PhosphoSite2
REFSEQ proteins: NP_006507.2
ENSEMBL proteins: ENSP00000361578 ENSP00000380214 ENSP00000361579
Human Recombinant Proteins Browse Origene for full length recombinant human proteins expressed in human HEK293 cells 
5/7 Gene Ontology (GO) cellular component terms (links to tree view) (see all 7
): About this table
Antibodies for SLC2A1: Assays for SLC2A1: | Protein
Domains/ Families for SLC2A1(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
| - Graphical View of Domain Structure for InterPro Entry P11166
ProtoNet protein and cluster: P11166 4 Blocks protein families: IPB000803 Mammalian facilitated glucose transporter family signature IPB002439 Glucose transporter type 1 (GLUT1) signature IPB003663 Sugar transporter signature IPB005829 Sugar transporter superfamily
UniProtKB/Swiss-Prot: GTR1_HUMAN, P11166Similarity: Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily | Gene Function for SLC2A1
(According to MGI Jun 06 2009, UniProtKB,
IUBMB,and/or Genatlas,
shRNA from
OriGene,
Sigma-Aldrich, RNAi from
Sigma-Aldrich,
RNAi Products,
Clones, and
Q-PCR Products
from Invitrogen,
Millipore,
OriGene, and/or
Abnova,
siRNAs from
Applied Biosystems,
SYBR primers from OriGene,
Cell-based Assays from Millipore,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_006516
Applied Biosystems Silencer® siRNAs for SLC2A1
Sigma-Aldrich siRNA and siRNA Panels for SLC2A1  Sigma-Aldrich shRNA for SLC2A1  Explore Sigma-Aldrich super-pooled esiRNAs 
              OriGene GFP tagged cDNA clone in CMV expression vector: NM_006516                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_006516                                  untagged cDNA clone in CMV expression vector: NM_006516 
Primers: Browse
Quantitative PCR Central at Invitrogen for Q-PCR LUX™ Primers               OriGene genome-wide validated SYBR primer pairs: NM_006516
UniProtKB/Swiss-Prot: GTR1_HUMAN, P11166Function: Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexosesGenatlas biochemistry entry for SLC2A1:solute carrier family 2,member A1,facilitated glucose transporter,not associated with susceptibility to NIDDM7 MGI mutant phenotypes (inferred from 1 allele ) (MGI details for Slc2a1):
5 Gene Ontology (GO) molecular function terms (links to tree view): | GO ID | Qualified GO term | Evidence | PubMed IDs |
|---|
| GO:0005215 | transporter activity |
IEA | -- | | GO:0005351 | sugar:hydrogen symporter activity |
IEA | -- | | GO:0005355 | glucose transmembrane transporter activity |
TAS | 9462754 | | GO:0005515 | protein binding |
IEA | -- | | GO:0022891 | substrate-specific transmembrane transporter activity |
IEA | -- | About this table | Pathways & Interactions for SLC2A1
(Pathways according to Invitrogen
(maps by GeneGo),
Millipore,
Cell Signaling Technology,
Sigma-Aldrich,
KEGG
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Proteins Network according to
SABiosciences,
Interactions according to 1UniProtKB,
2MINT, and/or
3STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|
3 Sigma-Aldrich "Your Favorite Gene" Pathways for SLC2A1 (Your Favorite Gene powered by Ingenuity) 
Gene Network CentralTM Interacting Genes and Proteins Network for SLC2A1 
5/66 Interacting proteins for SLC2A1 (P111662 ENSP000003615793) via UniProtKB, MINT, and/or STRING (see all 66
)About this table
3 Gene Ontology (GO) biological process terms (links to tree view): About this table
|
Drugs & Compounds for SLC2A1(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
Sigma-Aldrich, Tocris Bioscience, and/or
Novoseek and Drugs according to
Enzo Life Sciences and/or
PharmGKB)
About This Section
|  | Sigma-Aldrich Small Molecules for SLC2A1: Inhibitor |
Browse Tocris compounds for SLC2A1 10/33 Novoseek chemical compound relationships for SLC2A1 gene (see all 33
)
| Compound |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| glucose |
89.98 |
1848 |
2168170 (8), 18650261 (8), 15389572 (6), 11089547 (5) (see all 99) |
| cytochalasin b |
84.72 |
109 |
8942661 (5), 8810921 (5), 1716731 (4), 14643928 (3) (see all 40) |
| 3-o-methylglucose |
83.47 |
32 |
1599406 (3), 16928769 (2), 10715121 (2), 8626697 (1) (see all 16) |
| 2-n-4-(1-azi-2,2,2-trifluoroethyl)benzoyl-1,3-bis(d-mannos-4-yloxy)-2-propylamine |
72.84 |
1 |
8444835 (1) |
| iaps-forskolin |
71.72 |
1 |
2264820 (1) |
| 3-omg |
70.94 |
1 |
9724536 (1) |
| pimonidazole |
68.72 |
13 |
16242253 (4), 12532423 (3), 14520462 (2), 18973979 (2) |
| 18f fluorodeoxyglucose |
66.05 |
51 |
19317609 (5), 12926062 (4), 19360342 (2), 15362743 (2) (see all 18) |
| galp |
64.37 |
12 |
8168538 (5), 7929167 (3), 9182541 (1), 11342180 (1) (see all 6) |
| oligomycin b |
60.74 |
1 |
8892317 (1) |
About this table
|
Transcripts for SLC2A1(GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 219 Homo sapiens; Jun 2 2009) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
non coding RNAs according to
RNAdb,
ESTs according to GeneTide,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from Invitrogen,
Millipore, and/or
Abnova,
siRNAs from Applied Biosystems,
Sigma-Aldrich,
shRNA from
Sigma-Aldrich,
OriGene,
Tagged/untagged cDNA clones from
OriGene, Expression Assays from Applied Biosystems) About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_006516
Sigma-Aldrich siRNA and siRNA Panels for SLC2A1  Sigma-Aldrich shRNA for SLC2A1  Explore Sigma-Aldrich super-pooled esiRNAs 
Applied Biosystems Silencer® siRNAs: NM_006516 REFSEQ mRNAs for SLC2A1 gene: NM_006516.2
Applied Biosystems TaqMan ® Gene Expression Assays: NM_006516               OriGene GFP tagged cDNA clone in CMV expression vector: NM_006516                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_006516                                  untagged cDNA clone in CMV expression vector: NM_006516  Additional cDNA sequence: AB208987.1 AF070544.1 AK122999.1 AK292791.1 AK293306.1 AK296736.1 AK312403.1 AY034633.1 BC118590.1 BC121804.1 CR596198.1 CR596811.1 CR599895.1 CR600321.1 CR601030.1 CR601790.1 CR606197.1 CR606282.1 CR606581.1 CR618028.1 K03195.1 24/46 DOTS entries (see all 46
): DT.95069713 DT.100678799 DT.95069727 DT.91678781 DT.97855673 DT.95069724 DT.100678790 DT.91854288 DT.100645085 DT.121376287 DT.121376224 DT.121376359 DT.453395 DT.95069736 DT.100039361 DT.121376302 DT.100847216 DT.121376373 DT.95069687 DT.95146737 DT.100678789 DT.100834466 DT.100678793 DT.100678815 24/1138 AceView cDNA sequences (see all 1138
):BQ945062 CB409248 CR599895 C18705 BQ646155 AU130663 D11793 BG987803 AF070544 BM545441 AW418621 BM873553 BQ646901 BU552504 BG324417 AW675550 BG680895 BQ691238 BQ686431 AU129841 BI914623 BQ647312 BQ685946 BM724941
highest scoring ESTs for SLC2A1:AL551743 AU130791 AU131889 AU133323 BE407330 BE877842 BI252186 BX382300 BX385804 BX442153 Unigene Cluster for SLC2A1: Solute carrier family 2 (facilitated glucose transporter), member 1 Hs.706748 [show with all ESTs]Unigene Representative Sequence: NM_006516
GeneLoc Exon Structure
5/8 Alternative Splicing Database (ASD) splice patterns (SP) for SLC2A1 (see all 8
)
| ExUns: | 1a | · | 1b | · | 1c | ^ | 2 | ^ | 3a | · | 3b | ^ | 4a | · | 4b | · | 4c | · | 4d | ^ | 5a | · | 5b | · | 5c | · | 5d | ^ | 6 | ^ | 7 | ^ | 8a | · | 8b | ^ | 9 | ^ | 10 | ^ | 11a | · | 11b | · | 11c | |
| SP1: | |   | |   | |   | - |   | |   | |   | |   | |   | |   | - |   | - |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP2: | |   | |   | |   | |   | |   | |   | |   | |   | |   | - |   | |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP3: | |   | |   | |   | - |   | |   | |   | |   | |   | |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP4: | |   | |   | |   | - |   | |   | |   | |   | |   | |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP5: | |   | |   | |   | - |   | |   | - |   | - |   | - |   | |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   |
About this scheme
ECgene alternative splicing isoforms for SLC2A1
3 Ensembl transcripts including schematic representations: ENST00000372500
ENST00000397019
ENST00000372501
|
Expression for SLC2A1
(Experimental results according to
1GeneNote
and GNF BioGPS,
probe sets-to-genes annotations according to
2GeneAnnot ,
3GeneTide ,
Sets of similar genes according to GeneDecks,
Electronic Northern calculations according to data from
UniGene (Build 219 Homo sapiens),
SAGE tags according to
CGAP,
plus additional links to
SOURCE, and/or
GNF
BioGPS, and/or
EXPOLDB, and/or
UniProtKB,
Expression Assays from
Applied Biosystems
)
About This Section
| SLC2A1 expression in normal and diseased human tissues
Applied Biosystems TaqMan ® Gene Expression Assays for SLC2A1
1 / 2 / 3 5 probe-sets matching SLC2A1 gene Data from
(Publications) and GNF BioGPS About these images About these images
CGAP SAGE TAG: GAGACTCCTG
SOURCE GeneReport for Unigene cluster: Hs.706748
Expression variation in blood from EXPOLDB for SLC2A1 UniProtKB/Swiss-Prot: GTR1_HUMAN, P11166Tissue specificity: Expressed at variable levels in many human tissues |
Orthologs for SLC2A1
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
and/or
5MGI Jun 06 2009,
with possible further links to
Flybase
and/or
WormBase,
Gene Trees according to Ensembl)
About This Section
|
Orthologs for SLC2A1 gene from 5/17 species (see all 17
)
About this table Species with no ortholog for SLC2A1
ENSEMBL Gene Tree for SLC2A1 | Paralogs for SLC2A1(Paralogs according to 1HomoloGene and 2Ensembl, Pseudogenes according to 3Pseudogene.org) About This Section
| Paralogs for SLC2A1 gene
- SLC2A142 SLC2A22 SLC2A42 SLC2A32
|
SNPs/Variants for SLC2A1(According to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE, and
UniProtKB,
Linkage Disequilibrium by HapMap,
Genotyping Reagents from
Applied Biosystems)
About This Section
|
HapMap Linkage Disequilibrium images for SLC2A1 (up to first 250kb)
|
Disorders & Mutations for SLC2A1
(in which this Gene is Involved, According to
OMIM, UniProtKB,
Novoseek, PharmGKB,
Genatlas, GeneTests,
Blood group antigen gene mutations by BGMUT,
HGMD, GAD,
HuGE Navigator,
BCGD,
and/or TGDB.)
About This Section
|
OMIM: 138140 disorders: 606777 612126 612126 UniProtKB/Swiss-Prot: GTR1_HUMAN, P11166
Defects in SLC2A1 are the cause of autosomal dominant GLUT1 deficiency syndrome [MIM:606777]; also called blood-brain barrier glucose transport defect. This disease causes a defect in glucose transport across the blood-brain barrier. It is characterized by infantile seizures, delayed development, and acquired microcephaly Defects in SLC2A1 are the cause of dystonia type 18 (DYT18) [MIM:612126]. DYT18 is an exercise-induced paroxysmal dystonia/dyskinesia. Dystonia is defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT18 is characterized by attacks of involuntary movements triggered by certain stimuli such as sudden movement or prolonged exercise. In some patients involuntary exertion-induced dystonic, choreoathetotic, and ballistic movements may be associated with macrocytic hemolytic anemia10/96 Novoseek disease relationships for SLC2A1 gene (see all 96
)
| Disease |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| perineurioma |
67.08 |
4 |
12692193 (1), 15086844 (1), 18620729 (1), 18520438 (1) |
| microcephaly |
58.23 |
12 |
15152356 (1), 15622525 (1), 18614966 (1), 10323476 (1) (see all 10) |
| tumors |
52.36 |
408 |
8683296 (9), 18620729 (7), 8314336 (5), 17991316 (5) (see all 99) |
| developmental delay |
52.11 |
15 |
15622525 (1), 16217704 (1), 18614966 (1), 10323476 (1) (see all 14) |
| insulin resistance |
50.53 |
18 |
9950801 (2), 9801136 (2), 11436180 (2), 1569156 (1) (see all 12) |
| diabetic nephropathies |
50.02 |
26 |
15717166 (3), 11168944 (2), 15745834 (2), 15682272 (2) (see all 17) |
| hyperglycemia |
48.94 |
24 |
14688680 (2), 11080093 (2), 16413942 (2), 9766571 (2) (see all 15) |
| hemangioma |
41.88 |
37 |
17554865 (4), 10665907 (4), 17926859 (4), 17241430 (3) (see all 15) |
| granuloma pyogenic |
41.82 |
6 |
17241430 (4), 15469208 (1), 10665907 (1) |
| cancer |
40.70 |
118 |
9293784 (3), 17071132 (3), 17064593 (3), 18979289 (3) (see all 70) |
About this table
Genatlas disease: SLC2A1 infantile seizures,microcephaly,developmental delay and hypoglycorrhachia,caused by haploinsufficiency of the blood-brain barrier hexose carrier GeneTests: SLC2A1 Glucose Transporter Type 1 Deficiency Syndrome Human Gene Mutation Database: SLC2A1 Genetic Association Database: SLC2A1 Human Genome Epidemiology Navigator: SLC2A1 (17 documents)
|
Medical News for SLC2A1(Possibly Related Articles in
Doctor's Guide)
About This Section
| -- |
Publications for SLC2A1 (in
PubMed.
Associations of this gene to articles via
1Novoseek,
2HGNC,
3Entrez Gene,
4UniProtKB/Swiss-Prot,
5UniProtKB/TrEMBL,
6GAD, and/or
7PharmGKB)
About This Section
| 10/835 PubMed articles for SLC2A1 gene (see all 835
):- GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. (PubMed id 18451999)1, 2, 3, 4 Weber Y.G....Lerche H. (2008)
- Autosomal dominant transmission of GLUT1 deficiency. (PubMed id 11136715)1, 3, 4 Klepper J.... Voit T. (2001)
- Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome. (PubMed id 10980529)1, 3, 4 Wang D.... De Vivo D.C. (2000)
- Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. (PubMed id 15682272)1, 3, 6 Zintzaras E. and Stefanidis I. (2005)
- A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus. (PubMed id 15745834)1, 3, 6 Hodgkinson A.D....Demaine A.G. (2005)
- Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes. (PubMed id 11168944)1, 3, 6 Grzeszczak W....Szydlowska I. (2001)
- Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. (PubMed id 11477169)1, 3, 6 Tarnow L....Pedersen O. (2001)
- Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy. (PubMed id 11231353)1, 3, 6 Hodgkinson A.D....Demaine A.G. (2001)
- Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. (PubMed id 17081065)3, 4 Chi A....Hunt D.F. (2006)
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). (PubMed id 15489334)3, 4 Gerhard D.S....Malek J. (2004)
|
Search for SLC2A1
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing SLC2A1
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
and/or
H-InvDB)
About This Section
|
| Other Databases showing SLC2A1
(According to HUGE)
About This Section
| -- |
Specialized Databases showing SLC2A1(According to ATLAS, HORDE, IMGT, MTDB, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| Name | Description |
| GeneReviews | http://www.genetests.org/query?gene=SLC2A1 | | Wikipedia | http://en.wikipedia.org/wiki/GLUT1 |
|
| | | About This Section
| --
| Services for SLC2A1(Reagents available from Applied Biosystems, Antibodies and assays by Cell
Signaling Technology, Abcam, Novus Biologicals, Sigma-Aldrich, R&D Systems, Millipore, Abnova, and/or Invitrogen, Clones available from OriGene,and/or Invitrogen, Drugs and/or compounds by Sigma-Aldrich, Enzo Life Sciences, and/or Tocris Bioscience) About This Section
| 
 Products for SLC2A1:

 | |
 | | | | |
|
 |  |  |
| | | | Search Tocris compounds for SLC2A1 |
|
 |
 | | | |
GeneCards Homepage - Last full update: 2 Jul 2009
Incremental update: 13 Oct 2009
|